Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PROGNOSTIC MARKERS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 126 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Grangeot-Keros, L; Cointe, D
      Diagnosis and prognostic markers of HCMV infection

      JOURNAL OF CLINICAL VIROLOGY
    2. Resino, S; Sanchez-Ramon, S; Bellon, JM; Jimenez, JL; Munoz-Fernandez, MA
      Impaired interleukin-5 (IL-5) production by T cells as a prognostic markerof disease progression in human immunodeficiency virus type 1 (HIV-1)-infected children

      EUROPEAN CYTOKINE NETWORK
    3. Sarela, AI; Scott, N; Ramsdale, J; Markham, AF; Guillou, PJ
      Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas

      ANNALS OF SURGICAL ONCOLOGY
    4. Low, SE; Horsman, JM; Hancock, H; Walters, SJ; Hancock, BW
      Prognostic markers in malignant lymphoma: An analysis of 1,198 patients treated at a single centre

      INTERNATIONAL JOURNAL OF ONCOLOGY
    5. Mizera-Nyczak, E; Dyszkiewicz, W; Heider, KH; Zeromski, J
      Isoform expression of CD44 adhesion molecules, Bcl-2. p53 and Ki-67 proteins in lung cancer

      TUMOR BIOLOGY
    6. Kulik, J; Nowecki, ZI; Rutkowski, P; Ruka, W; Rochowska, M; Skurzak, H; Siedlecki, JA
      Detection of circulating melanoma cells in peripheral blood by a two-marker RT-PCR assay

      MELANOMA RESEARCH
    7. Winters, ZE; Hunt, NC; Bradburn, MJ; Royds, JA; Turley, H; Harris, AL; Norbury, CJ
      Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer: association with prognosis

      EUROPEAN JOURNAL OF CANCER
    8. Pucci, S; Mazzarelli, P; Rabitti, C; Giai, M; Gallucci, M; Flammia, G; Alcini, A; Altomare, V; Fazio, VM
      Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies

      ONCOGENE
    9. Ferrero, JM; Ramaioli, A; Largillier, R; Formento, JL; Francoual, M; Ettore, F; Namer, M; Milano, G
      Epidermal growth factor receptor expression in 780 breast cancer patients:A reappraisal of the prognostic value based on an eight-year median follow-up

      ANNALS OF ONCOLOGY
    10. Resino, S; Bellon, JM; Gurbindo, D; Munoz-Fernandez, MA
      Disruption in cytokine and chemokine production by T-cells in vertically HIV-1-infected children

      ACTA PAEDIATRICA
    11. Leonardo, E; Zanconati, F; Bonifacio, D; Di Bonito, L
      Immunohistochemical MIB-1 and p27(kip1) as prognostic factors in pleural mesothelioma

      PATHOLOGY RESEARCH AND PRACTICE
    12. Vogeli, TA; Ackermann, R
      Prognostic markers of urothelial cancer

      UROLOGE A
    13. Kirkali, G; Tuzel, E; Guler, C; Gezer, S; Kirkali, Z
      Significance of tissue laminin P-1 elastase and fibronectin levels in transitional cell carcinoma of the bladder

      EUROPEAN UROLOGY
    14. Vassilakopoulos, T; Troupis, T; Sotiropoulou, C; Zacharatos, P; Katsaounou, P; Parthenis, D; Noussia, O; Troupis, G; Papiris, S; Kittas, C; Roussos, C; Zakynthinos, S; Gorgoulis, V
      Diagnostic and prognostic significance of squamous cell carcinoma antigen in non-small cell lung cancer

      LUNG CANCER
    15. Miller, MK; Unger, PD; Bleiweiss, IJ
      Immunohistochemical analysis of prostate specific antigen in breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    16. Lengyel, E; Schmalfeldt, B; Konik, E; Spathe, K; Harting, K; Fenn, A; Berger, U; Fridman, R; Schmitt, M; Prechtel, D; Kuhn, W
      Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer

      GYNECOLOGIC ONCOLOGY
    17. Montgomery, E; Goldblum, JR; Greenson, JK; Haber, MM; Lamps, LW; Lauwers, GY; Lazenby, AJ; Lewin, DN; Robert, ME; Washington, K; Zahurak, ML; Hart, J
      Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: A follow-up study based on 138 cases from a diagnostic variability study

      HUMAN PATHOLOGY
    18. Martin, KJ; Graner, E; Li, Y; Price, LM; Kritzman, BM; Fournier, MV; Rhei, E; Pardee, AB
      High-sensitivity array analysis of gene expression for the early detectionof disseminated breast tumor cells in peripheral blood

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    19. Kymionis, GD; Dimitrakakis, CE; Konstadoulakis, MM; Arzimanoglou, I; Leandros, E; Chalkiadakis, G; Keramopoulos, A; Michalas, S
      Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?

      JOURNAL OF SURGICAL RESEARCH
    20. Bjornland, K; Bratland, A; Rugnes, E; Pettersen, S; Johansen, HT; Aasen, AO; Fodstad, O; Ree, AH; Maelandsmo, GM
      Expression of matrix metalloproteinases and the metastasis-associated geneS100A4 in human neuroblastoma and primitive neuroectodermal tumor cells

      JOURNAL OF PEDIATRIC SURGERY
    21. Aebersold, DM; Kollar, A; Beer, KT; Laissue, J; Greiner, RH; Djonov, V
      Involvement of the hepatocyte growth factor/scatter factor receptor c-met and of Bcl-x(L) in the resistance of oropharyngeal cancer to ionizing radiation

      INTERNATIONAL JOURNAL OF CANCER
    22. Ranelletti, FO; Almadori, G; Rocca, B; Ferrandina, G; Ciabattoni, G; Habib, A; Galli, J; Maggiano, N; Gessi, M; Lauriola, L
      Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma

      INTERNATIONAL JOURNAL OF CANCER
    23. Nocito, A; Kononen, J; Kallioniemi, OP; Sauter, G
      Tissue microarrays (TMAs) for high-throughput molecular pathology research

      INTERNATIONAL JOURNAL OF CANCER
    24. Duffy, MJ
      Biochemical markers in breast cancer: which ones are clinically useful?

      CLINICAL BIOCHEMISTRY
    25. Sebo, TJ; Cheville, JC; Riehle, DL; Lohse, CM; Pankratz, VS; Myers, RP; Blute, ML; Zincke, H
      Predicting prostate carcinoma volume and stage at radical prostatectomy byassessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen - A report of 454 cases

      CANCER
    26. Kim, H; Scorilas, A; Katsaros, D; Yousef, GM; Massobrio, M; Fracchioli, S; Piccinno, R; Gordini, G; Diamandis, EP
      Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer

      BRITISH JOURNAL OF CANCER
    27. Ren, JC
      High-throughput single-strand conformation polymorphism analysis by capillary electrophoresis

      JOURNAL OF CHROMATOGRAPHY B
    28. Lijovic, M; Fabiani, ME; Bader, J; Frauman, AG
      Prostate cancer: are new prognostic markers on the horizon?

      PROSTATE CANCER AND PROSTATIC DISEASES
    29. Gervaz, P; Blanchard, A; Pampallona, S; Mach, JP; Fontolliet, C; Gillet, M
      Prognostic value of postoperative carcinoembryonic antigen concentration and extent of invasion of resection margins after hepatic resection for colorectal metastases

      EUROPEAN JOURNAL OF SURGERY
    30. Belluco, C; Nitti, D; Frantz, M; Toppan, P; Basso, D; Plebani, M; Lise, M; Jessup, JM
      Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer

      ANNALS OF SURGICAL ONCOLOGY
    31. Sung, CJ; Zheng, Y; Quddus, MR; Kang, X; Zhang, ZF; Lauchlan, SC; Zheng, W
      p53 as a significant prognostic marker in endometrial carcinoma

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    32. Puduvalli, VK; Kyritsis, AP; Hess, KR; Bondy, ML; Fuller, GN; Kouraklis, GP; Levin, VA; Bruner, JM
      Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survival

      INTERNATIONAL JOURNAL OF ONCOLOGY
    33. Heimann, R; Hellman, S
      Individual characterisation of the metastatic capacity of human breast carcinoma

      EUROPEAN JOURNAL OF CANCER
    34. Alaiya, A; Roblick, U; Egevad, L; Carlsson, A; Franzen, B; Volz, D; Huwendiek, S; Linder, S; Auer, G
      Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma

      ANALYTICAL CELLULAR PATHOLOGY
    35. Hattinger, CM; Zoubek, A; Ambros, PF
      Molecular cytogenetics in Ewing tumors: Diagnostic and prognostic information

      ONKOLOGIE
    36. Heidenreich, B; Heidenreich, A; Sesterhenn, A; Srivastava, S; Moul, JW; Sesterhenn, IA
      Aneuploidy of chromosome 9 and the tumor suppressor genes p16(INK4) and p15(INK4B) detected by in situ hybridization in locally advanced prostate cancer

      EUROPEAN UROLOGY
    37. Jalava, PJ; Collan, YUI; Kuopio, T; Juntti-Patinen, L; Kronqvist, P
      Bcl-2 immunostaining: A way to finding unresponsive postmenopausal N+*breast cancer patients

      ANTICANCER RESEARCH
    38. Tanaka, Y; Harima, Y
      Oncoprotein expression predicts response to radiotherapy or thermoradiotherapy in human cervical cancer

      EXPERIMENTAL ONCOLOGY
    39. Mottolese, M; Benevolo, M; Del Monte, G; Buglioni, S; Papaldo, P; Nistico, C; Di Filippo, F; Vasselli, S; Vici, P; Botti, C
      Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    40. Yu, H; Bharaj, B; Vassilikos, EJK; Giai, M; Diamandis, EP
      Shorter CAG repeat length in the androgen receptor gene is associated withmore aggressive forms of breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    41. Middleton, LP; Palacios, DM; Bryant, BR; Krebs, P; Otis, CN; Merino, MJ
      Pleomorphic lobular carcinoma: Morphology, immunohistochemistry, and molecular analysis

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    42. Mera, J; Uchida, S; Nagase, M
      Clinicopathologic study on prognostic markers in IgA nephropathy

      NEPHRON
    43. Harrison, LE; Choe, JK; Goldstein, M; Meridian, A; Kim, SH; Clark, K
      Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients

      JOURNAL OF SURGICAL ONCOLOGY
    44. Silvestrini, R; Luisi, A; Zambetti, M; Cipriani, S; Valagussa, P; Bonadonna, G; Daidone, MG
      Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer

      INTERNATIONAL JOURNAL OF CANCER
    45. Haznedaroglu, IC; Benekli, M; Ozcebe, O; Savas, MC; Gullu IH; Dundar, SV; Kirazli, S
      Serum L-selectin and P-selectin levels in lymphomas

      HAEMATOLOGIA
    46. Schrader, M; Muller, M; Heicappell, R; Krause, H; Schulze, W; Miller, K
      Telomerase activity and expression of telomerase subunits in the testicular tissue of infertile patients

      FERTILITY AND STERILITY
    47. Beksac, M; Arat, M; Akan, H; Koc, H; Ilhan, O; Ozcan, M
      Circulating CD44 and intercellular adhesion molecule-1 levels in low gradenon-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-alpha-2a treatment

      CANCER
    48. Deming, SL; Nass, SJ; Dickson, RB; Trock, BJ
      C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance

      BRITISH JOURNAL OF CANCER
    49. Daidone, MG; Luisi, A; Martelli, G; Benini, E; Veneroni, S; Tomasic, G; De Palo, G; Silvestrini, R
      Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women

      BRITISH JOURNAL OF CANCER
    50. von Knobloch, R; Schullerus, D; Riedmiller, H; Kalble, T
      Allelic imbalance at chromosomes 5q, 8p and 17p as progression markers forbladder cancer?

      AKTUELLE UROLOGIE
    51. Lebret, T; Becette, V; Colau, A; Herve, JM; Molinie, V; Barre, P; Lugagne-Delpon, PM; Gentile, A; Baglin, C; Botto, H
      Study of monoclonal antibody Ki67 immunolabelling of renal cell carcinomaswith and without renal vein thrombosis.

      PROGRES EN UROLOGIE
    52. Belluco, C; Esposito, G; Bertorelle, R; Del Mistro, A; Fassina, A; Vieceli, G; Chieco-Bianchi, L; Nitti, D; Lise, M
      Absence of the cell cycle inhibitor p27(Kip1) protein predicts poor outcome in patients with stage I-III colorectal cancer

      ANNALS OF SURGICAL ONCOLOGY
    53. Kuenen-Boumeester, V; Timmermans, AM; De Bruijn, EMCA; Henzen-Logmans, SC
      Immunocytochemical detection of prognostic markers in breast cancer; technical considerations

      CYTOPATHOLOGY
    54. Christiansen, I
      Serum levels of soluble vascular cell adhesion; molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin's lymphomas (vol 61, pg 311, 1998

      EUROPEAN JOURNAL OF HAEMATOLOGY
    55. Nagura, S; Katoh, R; Kawaoi, A; Kobayashi, M; Obara, T; Omata, K
      Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas

      MODERN PATHOLOGY
    56. Soda, G; Antonaci, A; Bosco, D; Nardoni, S; Melis, M
      Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroidcarcinomas

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    57. Yokota, T; Imamura, M; Teshima, S; Suzuki, H; Tezuka, F; Kikuchi, S; Kunii, Y; Yamauchi, H
      c-erba-2, p53 protein expression and steroid hormone receptors in breast carcinomas: An immunohistochemical study

      ANTICANCER RESEARCH
    58. Merrie, AEH; Yun, K; van Rij, AM; McCall, JL
      Detection and significance of minimal residual disease in colorectal cancer

      HISTOLOGY AND HISTOPATHOLOGY
    59. Griffith, JK; Bryant, JE; Fordyce, CA; Gilliland, FD; Joste, NE; Moyzis, RK
      Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma

      BREAST CANCER RESEARCH AND TREATMENT
    60. Elias, JM; Rosenberg, B; Margiotta, M; Kutcher, C
      Antigen restoration of MIB-1 immunoreactivity in breast cancer: Combined use of enzyme predigestion and low temperature for improved measurement of proliferation indexes

      JOURNAL OF HISTOTECHNOLOGY
    61. Thompson, LDR; Becker, RC; Przygodzki, RM; Adair, CF; Heffess, CS
      Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas - A clinicopathologic study of 130 cases

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    62. Rosenberg, S
      The urokinase-type plasminogen activator and its receptor in cancer

      ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34
    63. Partridge, M
      Head and neck cancer and precancer: can we use molecular genetics to make better predictions?

      ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND
    64. Resino, S; Jimenez, JL; Gurbindo, D; Munoz-Fernandez, MA
      Prognostic markers of survival in infants younger than 12 months vertically infected by human immunodeficiency virus type-1

      MEDICINA CLINICA
    65. Gee, JMW; Robertson, JFR; Ellis, IO; Nicholson, RI; Hurst, HC
      Immunohistochemical analysis reveals a tumour suppressor-like role for thetranscription factor AP-2 in invasive breast cancer

      JOURNAL OF PATHOLOGY
    66. Willett, CG; Badizadegan, K; Ancukiewicz, M; Shellito, PC
      Prognostic factors in stage T3NO rectal cancer - Do all patients require postoperative pelvic irradiation and chemotherapy?

      DISEASES OF THE COLON & RECTUM
    67. Bozzetti, C; Nizzoli, R; Naldi, N; Guazzi, A; Camisa, R; Bella, MA; Cocconi, G
      Bcl-2 expression on fine-needle aspirates from primary breast carcinoma - Correlation with other biologic factors

      CANCER CYTOPATHOLOGY
    68. Diamandis, EP; Helle, SI; Yu, H; Melegos, DN; Lundgren, S; Lonning, PE
      Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma

      CANCER
    69. Francois, C; van Velthoven, R; De Lathouwer, O; Moreno, C; Peltier, A; Kaltner, H; Salmon, I; Gabius, HJ; Danguy, A; Decaestecker, C; Kiss, R
      Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas

      AJCP. American journal of clinical pathology
    70. Engler, H; Koeberle, D; Thuerlimann, B; Senn, HJ; Riesen, WF
      Diagnostic and prognostic value of biochemical markers in malignant bone disease: A prospective study on the effect of bisphosphonate on pain intensity and progression of malignant bone disease

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    71. VELANOVICH V; SZYMANSKI W
      LYMPH-NODE METASTASIS IN BREAST-CANCER - COMMON PROGNOSTIC MARKERS LACK PREDICTIVE VALUE

      Annals of surgical oncology
    72. VELANOVICH V
      AXILLARY LYMPH-NODE DISSECTION FOR BREAST-CANCER - A DECISION-ANALYSIS OF T1 LESIONS

      Annals of surgical oncology
    73. SABIN CA; MOCROFT A; LEPRI AC; PHILLIPS AN
      COFACTORS AND MARKERS OF DISEASE PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Journal of the Royal Statistical Society. Series A. Statistics in society
    74. NEES M; VANWIJNGAARDEN E; BAKOS E; SCHNEIDER A; DURST M
      IDENTIFICATION OF NOVEL MOLECULAR MARKERS WHICH CORRELATE WITH HPV-INDUCED TUMOR PROGRESSION

      Oncogene
    75. WANG PW; LIU RT; TUNG SC; CHIEN WY; LU YC; CHEN CH; KUO MC; HSIEH JR; WANG ST
      OUTCOME OF GRAVES-DISEASE AFTER ANTITHYROID DRUG-TREATMENT IN TAIWAN

      Journal of the Formosan Medical Association
    76. BORRE M; HOYER M; SORENSEN FB; NERSTROM B; OVERGAARD J
      ASSOCIATION BETWEEN IN-VIVO IODODEOXYURIDINE LABELING, MIB-1 EXPRESSION, MALIGNANCY GRADE AND CLINICAL STAGE IN HUMAN PROSTATE-CANCER

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    77. Christiansen, I; Sundstrom, C; Kalkner, KM; Bring, J; Totterman, TH
      Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin's lymphomas

      EUROPEAN JOURNAL OF HAEMATOLOGY
    78. DEIMALATESTA MLF; VENEZIANO M; PEPPICELLI M; LANZI G; MARZETTI L
      BIOLOGIC PROGNOSTIC FACTORS IN OVARIAN-CANCER - A REVIEW

      European journal of gynaecological oncology
    79. IYER SB; HULTIN LE; ZAWADZKI JA; DAVIS KA; GIORGI JV
      QUANTITATION OF CD38 EXPRESSION USING QUANTIBRITE(TM) BEADS

      Cytometry
    80. Harding, MA; Theodorescu, D
      Prognostic markers in localized prostate cancer: From microscopes to molecules

      CANCER AND METASTASIS REVIEWS
    81. KUTE TE; GRONDAHLHANSEN J; SHAO SM; LONG R; RUSSELL G; BRUNNER N
      LOW CATHEPSIN-D AND LOW PLASMINOGEN-ACTIVATOR TYPE-1 INHIBITOR IN TUMOR CYTOSOLS DEFINES A GROUP OF NODE-NEGATIVE BREAST-CANCER PATIENTS WITH LOW-RISK OF RECURRENCE

      Breast cancer research and treatment
    82. SYRIGOS KN; HARRINGTON K; WAXMAN J; KRAUSZ T; PIGNATELLI M
      ALTERED GAMMA-CATENIN EXPRESSION CORRELATES WITH POOR SURVIVAL IN PATIENTS WITH BLADDER-CANCER

      The Journal of urology
    83. YIP TTC; LAU WH; CHAN JKC; NGAN RKC; POON YF; LUNG CW; LO TY; HO JHC
      PROGNOSTIC-SIGNIFICANCE OF DNA FLOW CYTOMETRIC ANALYSIS IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA

      Cancer
    84. KEEGAN PE; LUNEC J; NEAL DE
      P53 AND P53-REGULATED GENES IN BLADDER-CANCER

      British Journal of Urology
    85. CHRISTIANSEN I; SUNDSTROM C; ENBLAD G; TOTTERMAN TH
      SOLUBLE VASCULAR CELL-ADHESION MOLECULE-1 (SVCAM-1) IS AN INDEPENDENTPROGNOSTIC MARKER IN HODGKINS-DISEASE

      British Journal of Haematology
    86. GROTHEY A; HEISTERMANN P; PHILIPPOU S; VOIGTMANN R
      SERUM LEVELS OF SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1, CD54) IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER - CORRELATION WITH HISTOLOGICAL EXPRESSION OF ICAM-1 AND TUMOR STAGE

      British Journal of Cancer
    87. SUTHIPINTAWONG C; LEONG ASY; CHAN KW; VINYUVAT S
      IMMUNOSTAINING OF ESTROGEN-RECEPTOR, PROGESTERONE-RECEPTOR, MIB1 ANTIGEN, AND C-ERBB-2 ONCOPROTEIN IN CYTOLOGIC SPECIMENS - A SIMPLIFIED METHOD WITH FORMALIN FIXATION

      Diagnostic cytopathology
    88. MOODLEY D; BOBAT RA; COOVADIA HM; DOORASAMY T; MUNSAMY S; GOUWS E
      LYMPHOCYTE SUBSET CHANGES BETWEEN 3 AND 15 MONTHS OF AGE IN INFANTS BORN TO HIV-SEROPOSITIVE WOMEN IN SOUTH-AFRICA

      TM & IH. Tropical medicine & international health
    89. NICHOLSON RI; GEE JMW; HARPER ME; ELLIS IO; WILLSHER P; ROBERTSON JFR
      ERBB SIGNALING IN CLINICAL BREAST-CANCER - RELATIONSHIP TO ENDOCRINE SENSITIVITY

      Endocrine-related cancer
    90. LISE M; LODA M; FIORENTINO M; MERCURIO AM; SUMMERHAYES IC; LAVIN PT; JESSUP JM
      ASSOCIATION BETWEEN SUCRASE-ISOMALTASE AND P53 EXPRESSION IN COLORECTAL-CANCER

      Annals of surgical oncology
    91. LEONARDI E; CRISTOFORI A; CAFFO O; DALLAPALMA P
      CYTOMETRIC DNA ANALYSIS AND PROGNOSTIC BIOMARKERS IN BREAST-CARCINOMA- EXPRESSION OF P53 PRODUCT IN THE DIFFERENT PLOIDY CLASSES

      Analytical cellular pathology
    92. ELLEDGE RM; GREEN S; HOWES L; CLARK GM; BERARDO M; ALLRED DC; PUGH R; CIOCCA D; RAVDIN P; OSULLIVAN J; RIVKIN S; MARTINO S; OSBORNE CK
      BCL-2, P53, AND RESPONSE TO TAMOXIFEN IN ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    93. BAAY MFD; DUK JM; GROENIER KH; BURGER MPM; DEBRUIJN HWA; HOLLEMA H; STOLZ E; HERBRINK P
      RELATION BETWEEN HPV-16 SEROLOGY AND CLINICOPATHOLOGICAL DATA IN CERVICAL-CARCINOMA PATIENTS - PROGNOSTIC VALUE OF ANTI-E6 AND OR ANTI-E7 ANTIBODIES/

      Cancer immunology and immunotherapy
    94. CASTILLAGUERRA L; MORENO AM; FERNANDEZMORENO MC; UTRILLA JC; FERNANDEZ E; GALERADAVISON H
      EXPRESSION AND PROGNOSTIC VALUE OF C-ERBB-2 ONCOGENE PRODUCT IN HUMANPHEOCHROMOCYTOMAS

      Histopathology
    95. SAKR WA; GRIGNON DJ
      PROSTATE-CANCER - INDICATORS OF AGGRESSIVENESS

      European urology
    96. TAYLOR CR; COTE RJ
      IMMUNOHISTOCHEMICAL MARKERS OF PROGNOSTIC VALUE IN SURGICAL PATHOLOGY

      Histology and histopathology
    97. ANAND AC; NIGHTINGALE P; NEUBERGER JM
      EARLY INDICATORS OF PROGNOSIS IN FULMINANT HEPATIC-FAILURE - AN ASSESSMENT OF THE KINGS CRITERIA

      Journal of hepatology
    98. GANSLER TS; HARDMAN W; HUNT DA; SCHAFFEL S; HENNIGAR RA
      INCREASED EXPRESSION OF FATTY-ACID SYNTHASE (OA-519) IN OVARIAN NEOPLASMS PREDICTS SHORTER SURVIVAL

      Human pathology
    99. COX LS
      MULTIPLE PATHWAYS CONTROL CELL-GROWTH AND TRANSFORMATION - OVERLAPPING AND INDEPENDENT ACTIVITIES OF P53 AND P21(CIP1 WAF1/SDI1)/

      Journal of pathology
    100. DIAMANDIS EP; NADKARNI S; BHAUMIK B; ABDELRAHMAN A; MELEGOS DN; BORCHERT G; BLACK MH; ALONSO M; SALAS A; DELOSTOYOS JR; SAMPEDRO A; LOPEZOTIN C
      IMMUNOFLUOROMETRIC ASSAY OF PEPSINOGEN-C AND PRELIMINARY CLINICAL-APPLICATIONS

      Clinical chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 04:30:58